Stay Informed on Key Developments

Investor News and Updates

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

331 - 340of 392 News

August 16, 2018

Following completion of the divestment of Crop Science businesses to BASF

Bayer: Conditions for beginning Monsanto integration fulfilled

August 01, 2018

Not intended for U.S. and UK Media

Bayer receives approval of new treatment regimen for Eylea® in the EU

July 31, 2018

LEO Pharma to expand its lead in medical dermatology with acquisition of Bayer’s prescription dermatology unit

July 27, 2018

Not intended for U.S. and UK Media

Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary or peripheral artery disease

June 19, 2018

Bayer concludes refinancing of the Monsanto acquisition by placing bonds with a volume of 5 billion euros

June 19, 2018

Bayer issues new bonds with a volume of 15 billion U.S. dollars

June 07, 2018

Bayer closes Monsanto acquisition

June 04, 2018

Bayer plans closing of Monsanto acquisition on June 7

June 03, 2018

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer resolves capital increase with subscription rights to finance the acquisition of Monsanto

May 29, 2018

U. S. Department of Justice conditionally approves Bayer’s proposed acquisition of Monsanto

Inform Yourself on Special Topics

Investor News and Updates

Control Weeds, Not Farming

Everything You Need to Know About Glyphosate

Managing Glyphosate Litigation

Managing and Mitigating PCB Litigation Risk